Rewriting the Hepatitis Playbook from B to C
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Infectious Diseases |
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read MorePosted by Andy Lundin | Apr 19, 2024 | Immunoassay Instrumentation |
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Read MorePosted by Andy Lundin | Mar 7, 2024 | Sexually Transmitted Diseases |
Thee American Medical Association launched a new toolkit to help increase screenings for HIV, STIs, viral hepatitis and latent tuberculosis.
Read MorePosted by Andy Lundin | Oct 20, 2023 | Diagnostic Technologies |
WHO updated its Essential Diagnostics List, a register of in vitro diagnostics supporting countries to make national diagnostic choices.
Read MorePosted by Melanie Hamilton-Basich | Jun 9, 2023 | Covid 19 |
Scientists used AI to develop a simple one-pot test for both COVID-19 and hepatitis that takes just a few minutes, and hope to improve the technology for other simpler COVID and hepatitis tests.
Read More